Resurface Therapeutics Overview

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $50K

  • Investors
  • 1

Resurface Therapeutics General Information

Description

Developer of a drug discovery platform designed to identify and develop therapies for cancer. The company focuses on identifying novel targets and developing small molecule drugs, enabling healthcare providers to offer improved treatment options for patients with oncological conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Duxbury, MA
  • United States
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • Duxbury, MA
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Resurface Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 16-Sep-2026 $50K Completed Startup
To view Resurface Therapeutics’s complete valuation and funding history, request access »

Resurface Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Standish Spring Investments Venture Capital Minority
To view Resurface Therapeutics’s complete investors history, request access »

Resurface Therapeutics FAQs

  • Where is Resurface Therapeutics headquartered?

    Resurface Therapeutics is headquartered in Duxbury, MA.

  • What industry is Resurface Therapeutics in?

    Resurface Therapeutics’s primary industry is Drug Discovery.

  • Is Resurface Therapeutics a private or public company?

    Resurface Therapeutics is a Private company.

  • What is Resurface Therapeutics’s current revenue?

    The current revenue for Resurface Therapeutics is .

  • How much funding has Resurface Therapeutics raised over time?

    Resurface Therapeutics has raised $50K.

  • Who are Resurface Therapeutics’s investors?

    Standish Spring Investments has invested in Resurface Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process